• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-Eluting Microspheres and Hepatocellular Carcinoma: Improving Outcomes Related to Drug or Better Practice?

作者信息

Metwalli Zeyad A, Davis Ryan M, Tewari Sanjit O

机构信息

Department of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, USA.

Department of Radiology, University of Missouri-Columbia, Columbia, USA.

出版信息

Cardiovasc Intervent Radiol. 2023 Apr;46(4):447-448. doi: 10.1007/s00270-023-03409-x. Epub 2023 Mar 17.

DOI:10.1007/s00270-023-03409-x
PMID:36930286
Abstract
摘要

相似文献

1
Drug-Eluting Microspheres and Hepatocellular Carcinoma: Improving Outcomes Related to Drug or Better Practice?药物洗脱微球与肝细胞癌：改善与药物相关的结局还是优化实践？
Cardiovasc Intervent Radiol. 2023 Apr;46(4):447-448. doi: 10.1007/s00270-023-03409-x. Epub 2023 Mar 17.
2
DEB TACE for Intermediate and advanced HCC - Initial Experience in a Brazilian Cancer Center.经动脉化疗栓塞术治疗中晚期肝癌——巴西一家癌症中心的初步经验
Cancer Imaging. 2017 Feb 6;17(1):5. doi: 10.1186/s40644-017-0108-6.
3
Huge Hepatocellular Carcinoma Treated with Radical Hepatectomy after Drug-eluting Bead Transarterial Chemoembolization.药物洗脱微球经动脉化疗栓塞术后行根治性肝切除治疗巨大肝细胞癌
Intern Med. 2019 Apr 15;58(8):1103-1110. doi: 10.2169/internalmedicine.1214-18. Epub 2019 Jan 10.
4
Five-Years Outcome Analysis of 142 Consecutive Hepatocellular Carcinoma Patients Treated with Doxorubicin Eluting Microspheres 30-60 μm: Results from a Single-Centre Prospective Phase II Trial.载多柔比星 30-60μm 微球治疗 142 例连续肝细胞癌患者的 5 年结果分析：单中心前瞻性 II 期试验结果。
Cardiovasc Intervent Radiol. 2019 Nov;42(11):1551-1562. doi: 10.1007/s00270-019-02260-3. Epub 2019 Jul 18.
5
Response rate and safety in patients with hepatocellular carcinoma treated with transarterial chemoembolization using 40-µm doxorubicin-eluting microspheres.使用 40μm 载多柔比星微球的经动脉化疗栓塞治疗肝细胞癌患者的缓解率和安全性。
J Cancer Res Clin Oncol. 2021 Jan;147(1):23-32. doi: 10.1007/s00432-020-03370-z. Epub 2020 Sep 2.
6
[Comparative effect of CalliSpheres drug loading microspheres and lipiodol transarterial chemoembolization in the treatment of huge primary liver cancer].[载药微球与碘化油经动脉化疗栓塞术治疗巨大原发性肝癌的对比研究]
Zhonghua Gan Zang Bing Za Zhi. 2019 Jun 20;27(6):460-462. doi: 10.3760/cma.j.issn.1007-3418.2019.06.014.
7
CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.与传统经动脉化疗栓塞术相比，载药微球经导管动脉化疗栓塞术治疗肝细胞癌患者疗效更佳且安全性相当。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819830751. doi: 10.1177/1533033819830751.
8
Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.载药微球与顺铂类药物经动脉化疗栓塞治疗肝细胞癌的疗效比较：倾向评分匹配分析。
AJR Am J Roentgenol. 2020 Sep;215(3):745-752. doi: 10.2214/AJR.19.21669. Epub 2020 Jun 22.
9
Chemoembolization of hepatocellular carcinoma with drug eluting beads.药物洗脱微球用于肝细胞癌的化疗栓塞
J Hepatol. 2007 Jul;47(1):157-8; author reply 159. doi: 10.1016/j.jhep.2007.04.003. Epub 2007 Apr 19.
10
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.载药微球肝动脉化疗栓塞治疗肝细胞癌：疗效及阿霉素药代动力学
J Hepatol. 2007 Mar;46(3):474-81. doi: 10.1016/j.jhep.2006.10.020. Epub 2006 Nov 29.

本文引用的文献

1
Transarterial Chemoembolization with Anthracyclines-Loaded Polyethylene Glycol Drug Eluting Microspheres for the Treatment of Hepatocellular Carcinoma: A Pooled Multicentric Analysis of Survival in 580 Patients.经聚乙二醇载药微球栓塞化疗治疗肝细胞癌：580 例患者生存的荟萃多中心分析。
Cardiovasc Intervent Radiol. 2023 Apr;46(4):436-446. doi: 10.1007/s00270-023-03362-9. Epub 2023 Feb 10.
2
Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial.钇 90 微球放射栓塞与载药微球化疗栓塞治疗不可切除肝细胞肝癌：TRACE Ⅱ 期随机对照试验结果。
Radiology. 2022 Jun;303(3):699-710. doi: 10.1148/radiol.211806. Epub 2022 Mar 8.
3
Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study.钇-90 放射性栓塞治疗不可切除单发 HCC：LEGACY 研究。
Hepatology. 2021 Nov;74(5):2342-2352. doi: 10.1002/hep.31819. Epub 2021 Jun 11.
4
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌。
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
5
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.与肝动脉化疗栓塞术相比，钇-90放射性栓塞术显著延长了肝细胞癌患者的疾病进展时间。
Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27.
6
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone.多柔比星洗脱微球与单纯微球栓塞治疗肝细胞癌的肝动脉栓塞随机试验
J Clin Oncol. 2016 Jun 10;34(17):2046-53. doi: 10.1200/JCO.2015.64.0821. Epub 2016 Feb 1.